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ABSTRACT 
Introduction 
There are multiple configurations of specialist nurses working in the field of Parkinson’s. Parkinson’s 
Nurse Specialists (PNSs) are recognised as playing a pivotal role; however, there is little published 
evidence to demonstrate their effectiveness. Further evidence is needed to establish which aspects of 
the PNSs provide the greatest benefit to people with Parkinson’s and their families, and the cost-
effectiveness of different models of care. 
 
Methods and analysis 
Realist approaches explain how and why programmes work (or not) through striving to answer the 
question: what works, for whom and under what circumstances. This research uses a realist evaluation 
and aims to integrate an economic analysis within the realist framework. We refer to this as ‘realist 
economic evaluation’. It comprises four phases: (1) developing resource sensitive initial programme 
theories (IPTs) using surveys to gain a better understanding of the role and impact (costs and benefits) 
of the PNSs; (2) testing the IPTs through qualitative interviews and quantitative data analysis; (3) 
evaluating the cost and resource use implications alongside the benefits associated with the role of 
the PDSs, and (4) iteratively refining the IPTs throughout the project. The IPTs will draw on both 
quantitative and qualitative data. The result of the study will be a series of refined programme 
theories, which will explain how specialist nurses work in the field of Parkinson’s in the UK, what 
impact they have on people with Parkinson’s and their families and carers, and at what cost. 
  
Ethics and dissemination 
Northumbria University, the Health Research Authority (HRA) and Health and Care Research Wales 
(HCRW) have approved this study. Key findings will be disseminated throughout the duration of the 
project online and through social media, and via annual and regional Parkinson’s meetings and the 
Parkinson’s UK Excellence Network. Academic dissemination will occur through publication and 
conference presentations. 
 
Article Summary 
Strengths and limitations of this study 
• To our knowledge, this is the first study to put realist economic evaluation into practice This 
is the first stakeholder-driven national study to explore in-depth the role and value of the PNS 
from multiple perspectives, whilst also exploring resource use, costs and cost-effectiveness. 
• Patient and public involvement (PPI) members have been involved in this research from the 
outset, through meaningful activity such as engaging in regular team meetings, recruiting 
other PwP and carers to be involved, developing surveys and promoting the study.  
• This is a large study with a large amount of data collection. We will likely have to prioritise the 
programme theories we study in-depth. This will be done in collaboration with PPI members.  
• In this study we want to integrate the realist and economic evaluation. As eluded to above, 
this is the first study to use a realist economic evaluation design, and, whilst there are standard 
practices with respect to data collection and analysis for realist evaluation and economic 
evaluation, there are none for realist economic evaluation. Thus, methods data collection and 
analysis will evolve with the study. However, the novelty of the design and time constraints, 
may limit the extent to which full integration of realist and economic approaches can be 
achieved.        
  
INTRODUCTION 
Rationale for evaluation: 
Parkinson’s Disease (PD) is the second most common neurodegenerative condition in the UK, affecting 
around 145,519 people.[1] It is a complex, progressive condition, often resulting in motor impairments 
(e.g. movement and mobility problems) and non-motor symptoms (e.g. sleep problems, cognitive 
impairment, depression and constipation).[2] The National Institute for Health and Care Excellence 
(NICE) guideline on PD[3] recommends that people with PD should have regular access to: clinical 
monitoring and medication adjustment; a continuing point of contact for support, including home 
visits when appropriate; and reliable information about clinical and social matters of concern. These 
resources can be provided by a Parkinson’s Nurse Specialist (PNS); a role that was created in response 
to recommendations from previous research.[4]  
 
The creation of the PNS role aimed to improve prognosis, through better education and support, and 
to reduce the impact of PD on people and their families and carers. The role complemented other 
members of the multi-professional team (MPT), however, it was identified that nursing interventions 
and priorities differ across the PD trajectory.[4] In 1992, the Parkinson’s Disease Society developed a 
team of nurses with a special interest and training in PD to improve standards and services for PwP.[5] 
A task force for the Parkinson’s Disease Society recommended that each PwP was assigned a key 
worker to co-ordinate care and recognise changes in the disease trajectory, in collaboration with MPT 
members.[6] Today, the PNS is still recognised as playing this pivotal role[7], with around 385 PNSs 
working in primary, secondary and tertiary care settings in the UK. However, NICE provides no detail 
around their role or caseload, and the guideline on PD[3] only references one single evaluation 
study.[8] Furthermore, stakeholders often describe the positive value of the PNS but there is little 
published evidence to demonstrate their effectiveness.  
 
Role of the PNS: 
The PNS provides assistance with ongoing management and follow-up through: medication review; 
clinical leadership; help with post-diagnostic counselling; education support and advice for people 
with Parkinson’s (PwP), carers and other staff; signposting to other services; and case management.[9] 
Many run clinics, undertake home visits, refer on and co-ordinate care packages.[10] PNSs are often 
the first point of contact for PwP, ensuring fast access to specialist care, whilst relieving pressure on 
neurologist/geriatricians with a special interest in PD.[9]  
 
PNS education and training: 
Parkinson’s UK offers an induction training programme for new PNSs. In 2018, Parkinson’s UK 
launched the new learning pathway for PNSs to signpost and suggest areas of further 
education/development and to support newly appointed PNSs and more experienced PNSs. The 
Parkinson’s Competency document,[11] describes the knowledge and skills required by the PNS to 
manage the care of PwP across healthcare settings. Over recent years, Neurology Nurses have been 
introduced in some areas to support PwP in what was traditionally a PNS role. Neurology Nurses care 
for people with a variety of neurological conditions in all healthcare settings.[9] However, it is unclear 
how many Neurology Nurses are currently caring for PwP in the UK, what training they have had and 
what services they provide. It is also unknown whether Neurology Nurses follow The Parkinson’s 
Competency document[11] to demonstrate the expected knowledge and skills of a specialist nurse 
working in the field of Parkinson’s.  
 
Evaluation of the role of the PNS: 
PwP living in the community supported by a PNS had improved subjective wellbeing at no extra cost, 
compared with those who were supported by GPs.[8] Compared with neurologists, PNSs provided 
longer consultations and paid more attention to patients’ concerns.[5] No differences have been 
found between the two job roles in terms of health outcomes for PwP, although Reynolds et al.[5] 
recognised the benefit of the two professions collaborating. In 2006, Eighty-nine PNSs were surveyed 
to examine job specification, perceptions of service delivery and views about assistance:[12] 80.9% of 
respondents had completed specialist training, 32.6% were prescribers and 60.7% had been in post 
for more than five years. The major barriers to service delivery were lack of time, lack of clerical help 
and heavy caseload. The study concluded that PNSs provided high quality, disease-specific care to 
PwP; however, nurses were concerned about the ability to maintain care standards. Another 
evaluation of the PNS role examined the perceived effectiveness, acceptability and efficacy among 
PwP, their carers and the MPT.[7] The highest satisfaction rating for a PwP was being able to contact 
the PNS if they developed side-effects from treatment, whilst lowest satisfaction was experienced 
when the PNS was unable to provide information on respite care.[7] A key finding was the value of 
the PNS in hospital and community settings, but further clarification of the PNS role in these settings 
was required. A Swedish study demonstrated the PNSs role in providing tailored and competent care 
to alleviate the impact of PD on daily life. For the PNS to be effective, they required practical skills, the 
ability to provide emotional support and needed theoretical knowledge of PD.[13] Further evidence 
is required about which aspects of the PNSs provide the greatest benefit and the cost-effectiveness of 
different models of care. To date there has been no evaluations of the role of the Neurology Nurse 
and the impact these nurses have on PwP.  
 
Gaps in the Evidence: 
For the purpose of this project, the term specialist nurse will be used from here on in, and refers to all 
specialist nurses working in what was traditionally a PNS role. There are significant challenges in 
collecting evidence about how PNSs achieve improvements in outcomes for PwP due to a plethora of 
issues: 
 
• There are multiple configurations of specialist nurses in the field of Parkinson’s with different roles 
and job titles, across and within different settings. 
• The scope of different service models in which specialist nurses operate is not understood.  
• The PNS competency document was published in 2006 but relied heavily on one research study 
and the knowledge, skills and competencies of the current specialist nurse community is 
unknown. 
• The value of the specialist nurse during each stage of PD is unclear. 
• Current facilitators and barriers to providing an effective specialist nurse service are poorly 
understood. 
 
Furthermore, there are significant challenges in identifying the outcome measures to evaluate the 
specialist nurse’s role: 
 
• Specialist nurses often work within MPTs, with different service models; attributing outcomes 
to the specialist nurse alone is challenging.  
• Specialist nurses cover most of the UK, making it neither possible nor ethical to establish a 
matched control group of PwP without access to a specialist nurse, against which to compare 
outcomes.  
• PD is a progressive condition, with all PwP showing levels of deterioration over time; using 
health outcomes is not a reliable or effective way of evaluating the value of specialist nurses.  
 
REALIST EVALUATION 
Realist evaluation is a theory driven approach[14] used to further understand complex interventions. 
The different specialist nurse models utilised throughout the UK can be thought of as ‘complex 
interventions’, as they involve several interacting components that are sensitive to context.[15] Realist 
approaches explain how and why programmes, policies and interventions work (or not) through 
striving to answer the question: what works, for whom and under what circumstances.[14, 16] In 
contemporary theory-driven evaluation, theories about a programme are developed in many different 
ways and are used for a variety of purposes.[17, 18] Realist evaluation proposes that for an 
intervention to work, resources (mechanism) must influence the reasoning (mechanism) of the 
targeted actors to cause them to adopt an intended behaviour, that in a specific context will lead to a 
specific outcome.[19] Outcome patterns are found within most social programmes[20] and realist 
evaluation focuses on exploring these observed differences. This is done by identifying and testing 
programme theories in the form of Context-Mechanism-Outcome configurations (CMOCs). CMOCs 
are developed using the formula: Intervention resources (M) are introduced in a context (C), in a way 
that enhances a change in reasoning (M). This alters the behaviour of participants, which leads to 
outcomes (O).[21] By iteratively developing, refining and testing programme theories, we will be able 
to understand how, why, for whom and in what circumstances specialist nurses produce desired and 
undesired outcomes for PwP and their families and carers.  
 
Evaluation questions and objectives: 
How do specialist nurses work in the field of Parkinson’s? For whom and in what circumstances do 
they work best?  
The research questions above are broad to allow the formulation of underlying assumptions about 
how specialist nurses work, and what impacts they are expected to have. This is a crucial starting point 
for realist evaluation and provides the basis for theory development.[14] 
 
The objectives of this study are: 
1) To develop and refine realist explanatory theories to understand better the underpinning 
mechanisms and facilitative contexts that lead to positive and negative outcomes when a 
specialist nurse is involved in the care of PwP.  
2) To ascertain the skills, knowledge, experience and job specification of the specialist nurse. 
3) To determine the level of key competencies (as measured by the PNS Competency 
Framework) within specialist nurses. 
4) To explore the specialist nurse role in the trajectory of PD. 
5) To explore and gain an understanding of the impact of the different models of specialist 
nursing on care. 
6) To share good practice across the specialist nurse community.  
7) To identify, measure and value the resource (cost) implications and outcomes (benefits) linked 
to the realist programme theories in order to provide explanations of the comparative cost-
benefit of different models of specialist nursing.  
8) To understand the perceived value and net financial impacts of specialist nurse interventions 
and make a robust case for commissioning. 
 
METHODS AND ANALYSIS 
We have used the RAMESES II reporting standards for realist evaluations[22] to structure our reporting 
of the study details, methods and analysis. 
 
Rationale for using a realist economic evaluation: 
Realist evaluation is increasingly used to evaluate complex health system interventions because of its 
appealing practical framework for making sense of them.[23] However, to be successfully and 
sustainably adopted, policy-makers, service managers and practitioners want public programmes to 
be affordable as well as effective.[24] This 2-year study uses a mixed methods realist framework 
incorporating an economic analysis to identify, measure and value the resource implications linked to 
the realist programme theories about the specialist nurse, as well as value the outcomes. Though 
exploratory in its endeavor at present, we will attempt to use this approach, herein referred to as 
‘realist economic evaluation’, to provide explanations of the comparative cost-benefits of different 
models of specialist nursing. We have therefore chosen to adopt a realist economic evaluation design 
because of its unique ability to address questions of what works, for whom, and in what 
circumstances, whilst also exploring resource use, costs and cost-effectiveness.[24]  
 
Design: 
This research uses a realist evaluation and aims to integrate an economic analysis within the realist 
framework. We refer to this as ‘realist economic evaluation’. In order to facilitate this, the study will 
comprise four phases. First, we will develop resource sensitive initial programme theories (IPTs) 
(herein referred to as economic informed IPTs) about how specialist nurses “work” (including 
associated costs and benefits) in the field of Parkinson’s, using surveys with specialist nurses, PwP and 
their families/carers, to capture similarities and differences in specialist nurses and models of delivery 
nationally (phase 1). Once we understand the different service models, quantitative analysis of the 
survey data and qualitive interviews will be conducted with a sample of specialist nurses, PwP and 
their family members/carers to further explore responses to the survey questions and refine the 
programme theories (phase 2). The identification and measurement of costs and benefits associated 
with the programme theories will be integrated and undertaken iteratively within the realist 
evaluation during phases 1 and 2, as the economic informed IPTs are developed and tested. We will 
also draw on secondary data sources to value the costs and benefits where appropriate. These 
economic informed programme theories will be used to compare the different specialist nursing 
models with respect to their effectiveness, costs and benefits (phase 3). The findings from all three 
phases will be integrated to iteratively refine the programme theories (phase 4). This unique design 
will provide a comprehensive and detailed realist economic evaluation. The four-phase study design 
can be seen in figure 1, although consistent with a realist approach, operationalisation of the study 
design is an iterative process.  
 
The study has been developed and will be overseen by an expert panel including: the research team, 
Parkinson’s Disease Nurse Specialist Association (PDNSA) representatives, nurse leads within the 
Parkinson’s Excellence Network, the Parkinson’s UK Service Development and Improvement Lead, 
three PwP and a carer.  
 
Developing potential IPTs 
An example of an initial programme theory, which includes ‘financial realist resources’,[24] is provided 
below (Table 1). IPTs developed as part of the initial funding application, were structured in line with 
the Parkinson’s Nurse Competency Framework[11] which covers: counselling, access, monitoring, 
symptoms management, and research and development.   
 
Table 1. Initial programme theory example 
 
Data collection methods: 
Phase 1: Developing the initial programme theories 
The expert panel reviewed previous PNS surveys and developed questions for a new specialist nurse 
survey. They also discussed potential links between resources, including economic resources (such as 
service and patient costs) and outcomes (such as service use, quality of life, and well-being). Initial 
theories and CMO configurations were therefore expanded to include theories around economic 
resource use (costs) and outcomes (benefits), we refer to these as economic informed IPTs. These 
economic informed IPTs were used to develop the questions in the surveys. In addition, PPI team 
members developed questions for two separate surveys: one for PwP and one for family 
members/carers of PwP. These initial engagements were informal and guided by the stakeholders to 
ensure we captured data relevant and useful to real life settings.  
 
The purpose of the nurse survey is to capture the models of delivery of specialist nurses working in 
the field of Parkinson’s. It will explore areas such as role, working practices, caseload, qualifications, 
experience and level of competence and will thus provide insight into the contexts, structures and 
strategies around specialist nurse interventions. Although we are specifically targeting Parkinson’s 
nurses, the survey will be open to any specialist practitioner (e.g. neurology nurses, physiotherapists, 
occupational therapists) whose day-to-day role involves caring for people with Parkinson’s. We 
anticipate over 400 responses. This will provide us with a large amount of quantitative data that we 
can compare and contrast and it will also help us to define the different service models of specialist 
nursing. We will recruit over a period of 6 months via Parkinson’s UK, local CRNs and social media. The 
PDNSA and National Institute for Health Research (NIHR) will also provide support with the 
identification of potential participants, particularly those who are not PNSs but are fulfilling that role. 
The survey will be promoted by the PDNSA, the expert panel group, the Parkinson’s UK Excellence 
Initial programme theory: Due to PNS’s advanced training (context) they have the skills and feel 
confident to deliver information on self-management to PwP (resource); PwP understand the 
strategies and have increased confidence to self-manage (reasoning) which leads to a reduction in 
seeking care and fewer interactions with healthcare professionals (outcomes). 
 
Network and local PNS groups. All study information and a link to the survey will be shared on a 
Northumbria University website, which potential participants will be directed to.  
 
The purpose of the surveys for PwP and carers is to gain a better understanding of the role of the 
specialist nurse and the impact they have on the lives of PwP and their carers, thus providing insight 
into the mechanisms triggered by specialist nurse interventions and the associated outcomes. The 
surveys will be open to any person diagnosed with idiopathic Parkinson’s disease and any family 
member, friend or informal carer of a person with idiopathic Parkinson’s disease. The surveys for PwP 
and families/carers will explore areas such as access to a specialist nurse (i.e. when, where, for how 
long), information and support provided by a specialist nurse, and perceived benefits, limitations and 
impact of their specialist nurse on their health and wellbeing (collected using validated quality of life, 
satisfaction questionnaires[25, 26] and service use measures). We will recruit over a period of 6 
months via Parkinson’s UK, specialist nurses, local CRNs and social media channels, using the study’s 
website link.  
 
At the end of this phase, the information collected will provide the research team with data to finalise 
the economic informed PTs, using retroduction to infer relationships between items investigated in 
the surveys. This is referred to as theory gleaning through survey work.[27] For example, if the nurse 
survey indicates that there are more telephone services available throughout the UK and the PwP 
survey indicates that this is preferential, theorising (using the survey results) will take place around 
why this is preferential, how and for who, including theorising around the additional costs (positive 
and negative i.e. cost savings) and benefits (positive and negative) of providing the service. All survey 
participants will be asked if they would be happy to take part in a semi-structured interview to further 
explore the role of the specialist nurse and the issues identified in the survey. Those who select “yes” 
will be invited to provide their email address so that they can be contacted directly by the research 
team.  
 
Phase 2: Testing the initial programme theories 
Following the specialist nurse survey, up to 15 specialist nurses will be invited to participate in realist 
interviews to explore their perceptions of their role and activities. Participants will be purposively 
selected to ensure a cross-section of the different specialist nurses is represented (i.e. community-
based PNS, hospital-based PNS and other specialist nurses working in the field of Parkinson’s).  
Realist interviews will also be conducted with up to 15 PwP and 10 family members/carers. 
Participants will be purposively selected to ensure comparisons can be made across the different 
models of specialist nursing. Only those PwP with a diagnosis of idiopathic PD according to the UK 
Brain Bank Criteria,[28] with capacity and ability to give written informed consent, will be recruited. 
PwP with no access to a specialist nurse will be able to complete the survey but will be directed to 
appropriate questions, and will be given the opportunity to take part in an interview.  
Data from the surveys and semi-structured interviews will allow us to examine the impact of the 
specialist nurse and test the economic informed programme theories developed in phase 1.  
 
 
Phase 3: Economic evaluation 
To date, economic evaluations in PD have compared nurse versus GP or consultant led services.[5, 8] 
It could be argued that in order to harness the benefits of multi-professional working, both 
professional groups are needed to work collaboratively in order to provide quality of care. As such, a 
more informative evaluation would be to determine the most efficient service delivery model of the 
specialist nurse. 
 
Drawing on and expanding realist economic evaluation principles laid out by Anderson et al.,[24] we 
will employ a cost-benefit analysis to compare the resource requirements (costs) and value the 
outcomes (benefits including the wider, social benefits beyond mental and physical wellbeing) 
associated with programme theories that underpin the different specialist nurse models. As described 
above, economic informed programme theories, will be iteratively developed through Phase 1 (initial 
programme theory development) and Phase 2 (testing programme theories). At the end of Phase 1 
we will have a set of programme theories about the different models of specialist nurse provision that 
also identify the health economic implications in terms of resource use (such as service and patient 
costs) and outcomes (such as service use, quality of life, and well-being). At the end of Phase 2 we will 
have tested these programme theories using resources use and outcome data to provide a greater 
understanding of the relationship between context, mechanism, and health economic outcomes 
(costs and benefits). It is not possible at this stage to state exactly what resource and outcome data 
will be required for the analysis until we understand the resource use and outcome implications that 
will evolve within the economic informed realist programme theories. As an example they will likely 
include measures of staff training, time, travel, referrals, equipment, social support, patient and carer 
resource use, OOH care, 999/111 ambulance calls, A&E attendances, non-elective admissions, GP 
visits, telephone consultations, symptoms management, quality and life and well-being measures. 
These data will be gathered prospectively in the surveys and interviews where possible (for example, 
we have included health service utilisation measures in the surveys), and also retrospectively using 
secondary data such as the Excellence Network Data Dashboards[29], to evaluate the differences and 
trends in hospital admissions. Resource use will be costed at standard national tariffs.  
By the end of Phase 4 (see below), the refined economic informed programme theories will be used 
to build a comparative model the effectiveness, costs and benefits of the different services of specialist 
nurse provision. Whilst this is the form we expect the realist economic evaluation to take, this is 
ground-breaking new research and therefore we will employ an explorative approach; maintaining 
flexibility with the methods and being driven by programme theory, in line with the realist approach. 
 
Phase 4: Refining the programme theories 
Although theory refinement is presented as a separate phase, it will take place throughout the 
duration of the project as per the iterative nature of realist evaluation. This will be done via team 
meetings where we will think about and discuss the programme theories individually and what the 
data adds to them.  
 
 
 
Data Analysis 
The project will utilise an overarching realist framework and qualitative data will be analysed using a 
realist logic of analysis.[14] All interviews will be audio-recorded (subject to informed consent) and 
transcribed verbatim. The transcriptions will be coded using the NVivo qualitative data analysis 
software to allow refinement of the programme theories. This will be done by coding data under the 
following headings: context, mechanism, outcome, potential CMOC, supports/refutes/refines, 
how/why/decision-making processes, links to other IPTs, and additional notes.[30] As new questions 
emerge and connections are established, the literature will be revisited, thus deepening 
understanding and meaning of the findings.[31] This iterative and reflective process will serve as a tool 
for analysis and will allow greater transparency for how and why the CMOCs are developed and 
refined.[30] 
 
Quantitative data analysis will be supported by the statistical software package IBM SPSS (IBM Corp, 
Armonk, NY, USA) and will be overseen by an experienced statistician. Data will be summarised using 
appropriate summary statistics (e.g. mean, median, proportion), depending on the level and nature 
of the data (e.g. parametric, non-parametric, ordinal, frequency). Likewise, inferential analysis (e.g. t-
tests, Mann-Whiney U tests, Chi-squared tests) will be used as appropriate to the data to complement, 
inform and support qualitative analysis. 
 
The programme theories will draw on both quantitative and qualitative data, with quantitative data 
often consisting of outcomes and qualitative data used to explain associated contexts and 
mechanisms.[14] The data collection methods are therefore thoroughly integrated. By integrating the 
findings across the four phases, we will be able to refine the programme theories and explain how 
specialist nurses work in the field of Parkinson’s in the UK and what impact they have on PwP and 
their families and carers.  
 
PATIENT AND PUBLIC INVOLVEMENT 
PPI team members have been involved in this research from the outset. In an initial meeting in May 
2019, three PwP and a carer volunteered to be actively involved in the design, management, 
recruitment and conduct of this study. They recruited three more PwP/family members/carers for 
survey development consultations, which took place in July and October 2019. This additional PPI 
recruitment enables the burden of work to be shared and ensures consistent PPI input in the 
unfortunate case of illness. The discussions of the consultations enabled us to develop questions for 
the PwP and carer surveys and supported IPT development. PPI members have also been involved in 
promoting the study via social media; the study website features information about them and they 
are co-authors of this protocol. 
 
ETHICS AND DISSEMINATION 
Ethical approval 
This research was approved through Northumbria University’s Ethical Approval System (reference 
number: 17683) and the Health Research Authority (HRA) and Health and Care Research Wales 
(HCRW) (REC reference number: 19/EE/0254). 
 
Dissemination of Findings 
Key findings will be disseminated via the study website throughout the duration of the project. We 
have an active Twitter account for the study and we will continuously post updates and direct people 
to the website. Parkinson’s UK and the Excellence Network will support promotion of the study and 
dissemination of the findings throughout the project via direct emails to mailing lists, annual and 
regional nurse meetings, conferences, newsletters, online news pages and an online ‘Take Part Hub’. 
Learnings and improvements in service delivery approaches will be implemented when the 
information becomes available, rather than after the full research cycle has been completed. Such an 
approach will make policy and practice-relevant research immediately available to end users, 
accelerating the use of evidence in decision-making of health and other services.[32] Academic 
dissemination will occur through publication and conference presentations. 
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Figure Legend 
Figure 1: Operationalisation of a four-phase realist economic evaluation  
  
REFERENCES 
1. Parkinson's UK. The incidence and prevalence of Parkinson’s in the UK. 2018  12th 
November]; Available from: 
https://www.parkinsons.org.uk/professionals/resources/incidence-and-prevalence-
parkinsons-uk-report. 
2. D'Amelio, M., et al., Predictors of caregiver burden in partners of patients with Parkinson's 
disease. Neurol Sci, 2009. 30(2): p. 171-4. 
3. NICE Guideline (NG71). Parkinson's Disease in adults. 2017; Available from: 
https://www.nice.org.uk/guidance/ng71. 
4. MacMahon, D.G. and S. Thomas, Practical approach to quality of life in Parkinson's disease: 
the nurse's role. J Neurol, 1998. 245 Suppl 1: p. S19-22. 
5. Reynolds, H., J. Wilson-Barnett, and G. Richardson, Evaluation of the role of the Parkinson's 
disease nurse specialist. International journal of nursing studies, 2000. 37: p. 337-49. 
6. Thomas S, MacMahon DG, and Maguire J., Moving and shaping: a guide to commissioning 
integrated services for people with Parkinson’s disease. 2006, Parkinson’s Disease Society: 
London. 
7. Cook, N., et al., The role of a Parkinson's disease nurse specialist as perceived by 
professionals in Northern Ireland. British Journal of Neuroscience Nursing, 2007. 3(10): p. 
472-479. 
8. Jarman, B., et al., Effects of community based nurses specialising in Parkinson's disease on 
health outcome and costs: randomised controlled trial. BMJ (Clinical research ed.), 2002. 
324(7345): p. 1072-1075. 
9. Royal College of Nursing. 2018  [cited 2019 8th August]; Available from: 
https://www.rcn.org.uk/clinical-topics/neuroscience-nursing. 
10. Noble, C., Parkinson's disease and the role of nurse specialists. Nursing Standard, 1998. 
12(22): p. 32-33. 
11. Parkinson's UK, Competencies: A competency framework for nurses  working in Parkinson’s 
disease management. 2016. 
12. Axelrod, L., et al., Workloads of Parkinson's specialist nurses: implications for implementing 
national service guidelines in England. J Clin Nurs, 2010. 19(23-24): p. 3575-80. 
13. Hellqvist, C. and C. Berterö, Support supplied by Parkinson's disease specialist nurses to 
Parkinson's disease patients and their spouses. Applied Nursing Research, 2015. 28(2): p. 86-
91. 
14. PAWSON, R. and N. TILLEY, Realistic Evaluation. 1997, London: Sage. 
15. Craig, P., et al., Developing and evaluating complex interventions: the new Medical Research 
Council guidance. BMJ, 2008. 337: p. a1655. 
16. Pawson, R. and A. Manzano-Santaella, A realist diagnostic workshop. Evaluation, 2012. 
18(2): p. 176-191. 
17. Birckmayer, J.D. and C.H. Weiss, Theory-based evaluation in practice: what do we learn? 
Evaluation review, 2000. 24(4): p. 407-431. 
18. Donaldson, S., Donaldson, S. I. (2007). Program theory-driven evaluation science: Strategies 
and applications. Mahwah, NJ: Erlbaum. 2007. 
19. Mukumbang, F.C., et al., Unearthing how, why, for whom and under what health system 
conditions the antiretroviral treatment adherence club intervention in South Africa works: A 
realist theory refining approach. BMC Health Serv Res, 2018. 18(1): p. 343. 
20. Pawson, R. and N. Tilley. Realist Evaluation. 2004  [cited 2018 4 August]; Available from: 
http://www.communitymatters.com.au/RE_chapter.pdf. 
21. Dalkin, S.M., et al., What’s in a mechanism? Development of a key concept in realist 
evaluation. Implementation Science, 2015. 10. 
22. Wong, G., et al., RAMESES II reporting standards for realist evaluations. BMC medicine, 2016. 
14(1): p. 96. 
23. Moore, G.F., et al., Process evaluation of complex interventions: Medical Research Council 
guidance. bmj, 2015. 350: p. h1258. 
24. Anderson, R. and R. Hardwick, Realism and resources: Towards more explanatory economic 
evaluation. Evaluation, 2016. 22(3): p. 323-341. 
25. Jenkinson, C., et al., The Parkinson's Disease Questionnaire (PDQ-39): development and 
validation of a Parkinson's disease summary index score. Age Ageing, 1997. 26(5): p. 353-7. 
26. Pillas, M., et al., Development and validation of a carers quality-of-life questionnaire for 
parkinsonism (PQoL Carers). Qual Life Res, 2016. 25(1): p. 81-8. 
27. Manzano, A., The craft of interviewing in realist evaluation. Evaluation, 2016. 22(3): p. 342-
360. 
28. Daniel, S.E. and A.J. Lees, Parkinson's Disease Society Brain Bank, London: overview and 
research. Journal of neural transmission. Supplementum, 1993. 39: p. 165-172. 
29. Parkinson's UK Excellence Network and Wilmington Healthcare. Excellence Network Data 
Dashboards. 2017  [cited 2019 3rd September]; Available from: 
https://www.parkinsons.org.uk/professionals/resources/excellence-network-data-
dashboards. 
30. Gilmore, B., et al., Data Analysis and Synthesis Within a Realist Evaluation: Toward More 
Transparent Methodological Approaches. International Journal of Qualitative Methods, 
2019. 18: p. 1609406919859754. 
31. Berkowitz, S. Analyzing qualitative data. In J. Frechtling & L. Sharp (Eds.), User-friendly 
handbook for mixed method evaluations. Division of Research, Evaluation and 
Communication, National Science Foundation 1997  [cited 2019 06 December]; Available 
from: http://www.nsf.gov/pubs/1997/nsf97153/start.htm. 
32. Wolfenden, L., et al., Embedding researchers in health service organizations improves 
research translation and health service performance: the Australian Hunter New England 
Population Health example. Journal of Clinical Epidemiology, 2017. 85: p. 3. 
 
 
 
 
 
  
Authors’ contributions 
AH conceived the study and developed the study protocol. SB led the writing of the manuscript with 
input from SD, AB, AH, KB, AC, RB and CA. SD and AB developed the realist economic evaluation 
component of the methods. All authors reviewed and critiqued the manuscript and approved the final 
published version. 
 
Funding 
This study is funded by Parkinson’s UK (Grant reference: G-1807). 
 
Competing interests 
None declared. 
